Gene expression profiling of familial and sporadic interstitial pneumonia.
暂无分享,去创建一个
Ivana V. Yang | John W Hollingsworth | D. Schwartz | K. Brown | M. Steele | M. Schwarz | I. Yang | M. Speer | Erin Mcelvania-Tekippe | David A Schwartz | Lauranell H Burch | Ivana V Yang | T. Sporn | J. Hollingsworth | Marcy C Speer | Marvin I Schwarz | L. Burch | Mark P Steele | Jordan D Savov | Erin McElvania-Tekippe | Katherine G Berman | Thomas A Sporn | Kevin K Brown | J. Savov | K. Berman
[1] V. M. Riccardi,et al. Von Recklinghausen neurofibromatosis. , 1981, The New England journal of medicine.
[2] W. Craig,et al. A protective role for T lymphocytes in asbestos-induced pulmonary inflammation and collagen deposition. , 1994, American journal of respiratory cell and molecular biology.
[3] D. Schwartz,et al. Susceptibility to asbestos-induced and transforming growth factor-beta1-induced fibroproliferative lung disease in two strains of mice. , 2002, American journal of respiratory cell and molecular biology.
[4] R. Crystal,et al. Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members. , 1986, The New England journal of medicine.
[5] M. Burdick,et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. , 2004, The Journal of clinical investigation.
[6] Paul J. Friedman,et al. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.
[7] J. Kelsey,et al. Idiopathic pulmonary fibrosis: challenges and opportunities for the clinician and investigator. , 2005, Chest.
[8] P. Polakoff,et al. PREVALENCE OF RADIOGRAPHIC ABNORMALITIES AMONG NORTHERN CALIFORNIA SHIPYARD WORKERS * , 1979, Annals of the New York Academy of Sciences.
[9] R. Lilis,et al. ASBESTOS DISEASE IN UNITED STATES SHIPYARDS * , 1979, Annals of the New York Academy of Sciences.
[10] C. Martin,et al. Involvement of the lungs in tuberous sclerosis. , 1970, Chest.
[11] C. Carrington,et al. Familial chronic interstitial pneumonia. , 2015, The American review of respiratory disease.
[12] E. Hughes. Familial Interstitial Pulmonary Fibrosis , 1964, Thorax.
[13] V. Ferrans,et al. Susceptibility to experimental interstitial lung disease is modified by immune- and non-immune-related genes. , 1987, The American review of respiratory disease.
[14] Naftali Kaminski,et al. Up-Regulation and Profibrotic Role of Osteopontin in Human Idiopathic Pulmonary Fibrosis , 2005, PLoS medicine.
[15] R. Homer,et al. Regulation of pulmonary fibrosis by chemokine receptor CXCR3. , 2004, The Journal of clinical investigation.
[16] Jonathan Haines,et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. , 2002, American journal of respiratory and critical care medicine.
[17] A. Nicholson,et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. , 1999, American journal of respiratory and critical care medicine.
[18] G. Laurent,et al. Pulmonary fibrosis: searching for model answers. , 2005, American journal of respiratory cell and molecular biology.
[19] Naftali Kaminski,et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[20] L. Mccormack,et al. Familial Hamman-Rich syndrome. Report of eight cases. , 1969, Diseases of the chest.
[21] J. Auwerx,et al. Defective host defence mechanisms in a family with hypocalciuric hypercalcaemia and coexisting interstitial lung disease. , 1985, Clinical and experimental immunology.
[22] N. Kaminski. Microarray analysis of idiopathic pulmonary fibrosis. , 2003, American journal of respiratory cell and molecular biology.
[23] R. Strawderman,et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. , 2001, American journal of respiratory and critical care medicine.
[24] F. Green. Overview of pulmonary fibrosis. , 2002, Chest.
[25] U. Costabel,et al. ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias , 2002, European Respiratory Journal.
[26] Arnold Simanowitz,et al. international consensus statement , 2000 .
[27] S. Kunkel,et al. Role of Eotaxin-1 (CCL11) and CC chemokine receptor 3 (CCR3) in bleomycin-induced lung injury and fibrosis. , 2005, The American journal of pathology.
[28] C. Epstein,et al. Severe pulmonary involvement in adult Gaucher's disease. Report of three cases and review of the literature. , 1977, The American journal of medicine.
[29] H Page McAdams,et al. Clinical and pathologic features of familial interstitial pneumonia. , 2005, American journal of respiratory and critical care medicine.
[30] H. Clevers,et al. WNT signalling and haematopoiesis: a WNT–WNT situation , 2005, Nature Reviews Immunology.
[31] E. Hay,et al. DIRECT EVIDENCE FOR A ROLE OF β‐CATENIN/LEF‐1 SIGNALING PATHWAY IN INDUCTION OF EMT , 2002, Cell biology international.
[32] Naftali Kaminski,et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. , 2006, American journal of respiratory and critical care medicine.
[33] V. Poletti,et al. Aberrant Wnt/ (cid:1) -Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis , 2003 .
[34] M. Hallett,et al. Murine candidate bleomycin induced pulmonary fibrosis susceptibility genes identified by gene expression and sequence analysis of linkage regions , 2005, Journal of Medical Genetics.
[35] F. Martinez,et al. Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia , 2006, Journal of Clinical Pathology.
[36] J. Enghild,et al. Idiopathic Pulmonary Fibrosis , 2003 .
[37] S. Phan,et al. Bone marrow-derived progenitor cells in pulmonary fibrosis. , 2004, The Journal of clinical investigation.
[38] Hideo Sakamoto,et al. Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10. , 2004, American journal of respiratory cell and molecular biology.
[39] S. Javaheri,et al. Idiopathic pulmonary fibrosis in monozygotic twins. The importance of genetic predisposition. , 1980, Chest.
[40] M. Burdick,et al. CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling. , 2005, American journal of respiratory and critical care medicine.
[41] R. Terry,et al. Adult lipidosis resembling Niemann-Pick's disease. , 1954, The American journal of pathology.
[42] R. DePinho,et al. The Hermansky–Pudlak Syndrome: REPORT OF THREE CASES AND REVIEW OF PATHOPHYSIOLOGY AND MANAGEMENT CONSIDERATIONS , 1985, Medicine.
[43] David A. Lynch,et al. Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .
[44] A. Nicholson,et al. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. , 2000, American journal of respiratory and critical care medicine.
[45] W. Banks,et al. Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice. , 1998, Experimental lung research.
[46] J. Frymoyer,et al. A FAMILY STUDY OF IDIOPATHIC PULMONARY FIBROSIS. A POSSIBLE DYSPROTEINEMIC AND GENETICALLY DETERMINED DISEASE. , 1965, The American journal of medicine.